{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:08:18Z","timestamp":1774480098384,"version":"3.50.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polymetal International, plc"},{"name":"Russian Ministry of Science and Higher Education","award":["Advanced Digital Technologies (contract No. 075152020904, dated 16.11.2020)"],"award-info":[{"award-number":["Advanced Digital Technologies (contract No. 075152020904, dated 16.11.2020)"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic in Russia has already resulted in 500,000 excess deaths, with more than 5.6 million cases registered officially by July 2021. Surveillance based on case reporting has become the core pandemic monitoring method in the country and globally. However, population-based seroprevalence studies may provide an unbiased estimate of the actual disease spread and, in combination with multiple surveillance tools, help to define the pandemic course. This study summarises results from four consecutive serological surveys conducted between May 2020 and April 2021 at St. Petersburg, Russia and combines them with other SARS-CoV-2 surveillance data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted four serological surveys of two random samples (May\u2013June, July\u2013August, October\u2013December 2020, and February\u2013April 2021) from adults residing in St. Petersburg recruited with the random digit dialing (RDD), accompanied by a telephone interview to collect information on both individuals who accepted and declined the invitation for testing and account for non-response. We have used enzyme-linked immunosorbent assay CoronaPass total antibodies test (Genetico, Moscow, Russia) to report seroprevalence. We corrected the estimates for non-response using the bivariate probit model and also accounted the test performance characteristics, obtained from independent assay evaluation. In addition, we have summarised the official registered cases statistics, the number of hospitalised patients, the number of COVID-19 deaths, excess deaths, tests performed, data from the ongoing SARS-CoV-2 variants of concern (VOC) surveillance, the vaccination uptake, and St. Petersburg search and mobility trends. The infection fatality ratios (IFR) have been calculated using the Bayesian evidence synthesis model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>After calling 113,017 random mobile phones we have reached 14,118 individuals who responded to computer-assisted telephone interviewing (CATI) and 2,413 provided blood samples at least once through the seroprevalence study. The adjusted seroprevalence in May\u2013June, 2020 was 9.7% (95%: 7.7\u201311.7), 13.3% (95% 9.9\u201316.6) in July\u2013August, 2020, 22.9% (95%: 20.3\u201325.5) in October\u2013December, 2021 and 43.9% (95%: 39.7\u201348.0) in February\u2013April, 2021. History of any symptoms, history of COVID-19 tests, and non-smoking status were significant predictors for higher seroprevalence. Most individuals remained seropositive with a maximum 10 months follow-up. 92.7% (95% CI 87.9\u201395.7) of participants who have reported at least one vaccine dose were seropositive. Hospitalisation and COVID-19 death statistics and search terms trends reflected the pandemic course better than the official case count, especially during the spring 2020. SARS-CoV-2 circulation showed rather low genetic SARS-CoV-2 lineages diversity that increased in the spring 2021. Local VOC (AT.1) was spreading till April 2021, but B.1.617.2 substituted all other lineages by June 2021. The IFR based on the excess deaths was equal to 1.04 (95% CI 0.80\u20131.31) for the adult population and 0.86% (95% CI 0.66\u20131.08) for the entire population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Approximately one year after the COVID-19 pandemic about 45% of St. Petersburg, Russia residents contracted the SARS-CoV-2 infection. Combined with vaccination uptake of about 10% it was enough to slow the pandemic at the present level of all mitigation measures until the Delta VOC started to spread. Combination of several surveillance tools provides a comprehensive pandemic picture.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0266945","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:10:14Z","timestamp":1655302214000},"page":"e0266945","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-3326","authenticated-orcid":true,"given":"Anton","family":"Barchuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy","family":"Skougarevskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Kouprianov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-4176","authenticated-orcid":true,"given":"Daniil","family":"Shirokov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Dudkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rustam","family":"Tursun-zade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-9896","authenticated-orcid":true,"given":"Mariia","family":"Sergeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Tychkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-1255","authenticated-orcid":true,"given":"Andrey","family":"Komissarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Zheltukhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Lioznov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"Isaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Pomerantseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Zhikrivetskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Sofronova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Blagodatskikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"Titaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubov","family":"Barabanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria","family":"Danilenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"pone.0266945.ref001","doi-asserted-by":"crossref","first-page":"e69336","DOI":"10.7554\/eLife.69336","article-title":"Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset","volume":"10","author":"A Karlinsky","year":"2021","journal-title":"eLife"},{"key":"pone.0266945.ref002","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard; 2020."},{"issue":"5","key":"pone.0266945.ref003","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2468-2667(20)30089-X","article-title":"Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study","volume":"5","author":"T Tsang","year":"2020","journal-title":"The Lancet Public Health"},{"issue":"4","key":"pone.0266945.ref004","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10654-020-00635-2","article-title":"The paramount importance of serological surveys of SARS-CoV-2 infection and immunity","volume":"35","author":"J Goudsmit","year":"2020","journal-title":"European Journal of Epidemiology"},{"key":"pone.0266945.ref005","article-title":"Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study","author":"M Poll\u00e1n","year":"2020","journal-title":"The Lancet"},{"key":"pone.0266945.ref006","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","author":"S Stringhini","year":"2020","journal-title":"The Lancet"},{"key":"pone.0266945.ref007","article-title":"Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study","volume":"371","author":"R Pastor-Barriuso","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"pone.0266945.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-92206-y","article-title":"Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study","volume":"11","author":"A Barchuk","year":"2021","journal-title":"Scientific Reports"},{"key":"pone.0266945.ref009","article-title":"Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis","author":"X Chen","year":"2021","journal-title":"The Lancet Global Health"},{"key":"pone.0266945.ref010","article-title":"Excess deaths associated with COVID-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries","volume":"373","author":"N Islam","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"pone.0266945.ref011","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/1740-9713.01486","article-title":"Excess mortality reveals Covid\u2019s true toll in Russia","volume":"18","author":"D Kobak","year":"2021","journal-title":"Significance"},{"key":"pone.0266945.ref012","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","author":"A Sheikh","year":"2021","journal-title":"The Lancet"},{"issue":"26","key":"pone.0266945.ref013","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1056\/NEJMsr1813907","article-title":"Pathogen genomics in public health","volume":"381","author":"GL Armstrong","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"pone.0266945.ref014","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijid.2020.04.033","article-title":"Association of the COVID-19 pandemic with internet search volumes: a Google Trends analysis","volume":"95","author":"M Effenberger","year":"2020","journal-title":"International Journal of Infectious Diseases"},{"issue":"11","key":"pone.0266945.ref015","doi-asserted-by":"crossref","first-page":"e0241468","DOI":"10.1371\/journal.pone.0241468","article-title":"Human mobility trends during the early stage of the COVID-19 pandemic in the United States","volume":"15","author":"M Lee","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0266945.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77316-3","article-title":"Tracking COVID-19 using taste and smell loss Google searches is not a reliable strategy","volume":"10","author":"K Asseo","year":"2020","journal-title":"Scientific Reports"},{"key":"pone.0266945.ref017","article-title":"Evaluation of the performance of SARS-CoV-2 antibody assays for the longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia","author":"A Barchuk","year":"2021","journal-title":"Journal of Medical Virology"},{"issue":"1","key":"pone.0266945.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20880-z","article-title":"Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia","volume":"12","author":"A Komissarov","year":"2021","journal-title":"Nature Communications"},{"key":"pone.0266945.ref019","article-title":"The rise and spread of the SARS-CoV-2 AY. 122 lineage in Russia","author":"GV Klink","year":"2021","journal-title":"medRxiv"},{"key":"pone.0266945.ref020","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821002405","article-title":"Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data","volume":"149","author":"H Campbell","year":"2021","journal-title":"Epidemiology & Infection"},{"key":"pone.0266945.ref021","article-title":"Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection","author":"RA Harvey","year":"2021","journal-title":"JAMA Internal Medicine"},{"key":"pone.0266945.ref022","doi-asserted-by":"crossref","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","author":"KW Cohen","year":"2021","journal-title":"Cell Reports Medicine"},{"key":"pone.0266945.ref023","doi-asserted-by":"crossref","unstructured":"Gornyk D, Harries M, Gl\u00f6ckner S, Strengert M, Kerrinnes T, Bojara G, et al. SARS-CoV-2 seroprevalence in Germany \u2014 a population based sequential study in five regions; 2021.","DOI":"10.1101\/2021.05.04.21256597"},{"issue":"1","key":"pone.0266945.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21237-w","article-title":"SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic","volume":"12","author":"H Ward","year":"2021","journal-title":"Nature Communications"},{"key":"pone.0266945.ref025","article-title":"Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine","author":"M Watanabe","year":"2021","journal-title":"Diabetes\/Metabolism Research and Reviews"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:10:50Z","timestamp":1655302250000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266945"}},"subtitle":[],"editor":[{"given":"Siew Ann","family":"Cheong","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266945","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.31.21261428","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]}}}